Company Overview

 
 

OPKO Health

OPKO Health

What is OPKO Health OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals. The company develops treatments for secondary hyperparathyroidism, and has recently finished the patient recruitment for a Phase III trial against insufficiency in Vitamin D. Company Overview OPKO Health, Inc. is a diversified healthcare company that seeks to establish industry-leading positions in large, rapidly growing markets. Our pharmaceutical business features Rayaldee, a treatment for secondary hyperparathyroidism in stage 3-4 chronic kidney disease patients with vitamin D deficiency and VARUBI for chemotherapy-induced nausea andRead More


Esperion Therapeutics Cholesterol Drug Issue with FDA

Esperion Therapeutics Cholesterol Drug

Esperion Therapeutics Cholesterol Drug Esperion Therapeutics, Inc. is a public, American pharmaceutical company focused on the development of a first-in-class, orally available, small molecule designed to significantly lower elevated levels of LDL-C – with the reduced potential for muscle-related side effects associated with statin use. Company Overview Esperion is a pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol lowering therapies for the treatment of patients with elevated LDL-C. patients with elevated LDL-C have LDL-C levels not adequately controlled with current lipid-modifying therapies. Patients with elevated LDL-CRead More